Serum KL‐6 level is a prognostic marker in patients with anti‐MDA5 antibody‐positive dermatomyositis associated with interstitial lung disease

Abstract

The serum KL-6 levels may be a useful marker for predicting and monitoring ILD in Chinese patients with anti-MDA5⁺ DM, especially amyopathic DM phenotype.